These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23167333)

  • 1. Association between TP53 Arg72Pro polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Xu CT; Zheng F; Dai X; Du JD; Liu HR; Zhao L; Li WM
    Asian Pac J Cancer Prev; 2012; 13(9):4305-9. PubMed ID: 23167333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk.
    Liu ZH; Bao ED
    Mol Biol Rep; 2013 Mar; 40(3):2389-95. PubMed ID: 23184052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma.
    Zhang F; Li D; Li Y; Li H; Sun J; Li X; Li X
    Tumour Biol; 2014 Jan; 35(1):747-51. PubMed ID: 24046089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis.
    Peng Q; Lao X; Chen Z; Lai H; Deng Y; Wang J; Mo C; Sui J; Wu J; Zhai L; Yang S; Qin X; Li S
    PLoS One; 2013; 8(12):e82773. PubMed ID: 24376578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk.
    Wang F; Wang P; Wang B; Fu ZJ; Yuan Y; Yan SL; Zhao WJ; Wang YG
    Tumour Biol; 2014 Mar; 35(3):2723-8. PubMed ID: 24375191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk.
    Lv L; Wang P; Zhou X; Sun B
    Tumour Biol; 2013 Jun; 34(3):1451-9. PubMed ID: 23564481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between p53 Arg72Pro polymorphism and thyroid cancer risk: a meta-analysis.
    Wu B; Guo D; Guo Y
    Tumour Biol; 2014 Jan; 35(1):561-5. PubMed ID: 24037912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population.
    Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
    World J Gastroenterol; 2005 Jan; 11(2):289-92. PubMed ID: 15633234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between MDM2 SNP309, p53 Arg72Pro, and hepatocellular carcinoma risk: A MOOSE-compliant meta-analysis.
    Duan X; Li J
    Medicine (Baltimore); 2017 Sep; 96(36):e7856. PubMed ID: 28885338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro variant of TP53 Arg72Pro contributes to esophageal squamous cell carcinoma risk: evidence from a meta-analysis.
    Wang B; Wang D; Zhang D; Li A; Liu D; Liu H; Jin H
    Eur J Cancer Prev; 2010 Jul; 19(4):299-307. PubMed ID: 20389250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arg72Pro polymorphism of TP53 gene and the risk of skin cancer: a meta-analysis.
    Ye J; Li XF; Wang YD; Yuan Y
    PLoS One; 2013; 8(11):e79983. PubMed ID: 24260330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies.
    Tian X; Dai S; Sun J; Jiang S; Jiang Y
    Sci Rep; 2016 Apr; 6():24097. PubMed ID: 27053289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the TP53 codon 72 polymorphism and risk of oral squamous cell carcinoma in Asians: a meta-analysis.
    Zeng XT; Luo W; Geng PL; Guo Y; Niu YM; Leng WD
    BMC Cancer; 2014 Jun; 14():469. PubMed ID: 24969046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis.
    Jiang DK; Yao L; Wang WZ; Peng B; Ren WH; Yang XM; Yu L
    World J Gastroenterol; 2011 Mar; 17(9):1227-33. PubMed ID: 21448430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of association between the TP53 Arg72Pro polymorphism and risk of endometriosis based on case-control studies.
    Yan Y; Wu R; Li S; He J
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():1-7. PubMed ID: 25819169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association between
    Zhang A; Shi TY; Zhao Y; Xiang J; Yu D; Liang Z; Xu C; Zhang Q; Hu Y; Wang D; He J; Duan P
    Oncotarget; 2017 Dec; 8(68):112761-112769. PubMed ID: 29348863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study.
    Sümbül AT; Akkız H; Bayram S; Bekar A; Akgöllü E; Sandıkçı M
    Mol Biol Rep; 2012 Feb; 39(2):1639-47. PubMed ID: 21607615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of associations between the TP53 Arg72Pro polymorphism with risk of head and neck carcinomas based on case-control studies.
    Ren WH; Jiang DK; Pei Y; Wang SQ; Yang XM; Yu L
    Genet Mol Res; 2014 Jan; 13(1):103-14. PubMed ID: 24446292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies.
    Tian X; Dai S; Sun J; Jiang S; Jiang Y
    Oncotarget; 2017 Jan; 8(1):1156-1165. PubMed ID: 27901479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [p53 gene codon 72 polymorphism and genetic susceptibility to hepatocellular carcinoma in Chinese population].
    Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):76-9. PubMed ID: 15774209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.